CLINICAL_TRIALS
trial_result
· 2020-01-27
Clinical Trial Update: Ketamine in Adolescents With Treatment-Resistant Depression [Phase 2]
Summary
Phase 2 trial update on ketamine for adolescents with treatment-resistant major depressive disorder has completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Minnesota | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-01-27